The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS

Keyphrases

• Acute Decompensated Heart Failure 30%
• Adverse Effects 10%
• Amiodarone 20%
• Atrial Fibrillation 100%
• Cardiovascular Hospitalizations 20%
• Control Properties 20%
• Dronedarone 100%
• End Organ 10%
• Flutter 100%
• Hepatic Toxicity 10%
• High Risk 10%
• Increased Mortality 10%
• Iodine 10%
• Lipophilic 10%
• Long-term Treatment 10%
• Marketing Information 10%
• Methane 10%
• Multicenter Trial 10%
• Pallas 100%
• Permanent AF 20%
• Practice Guidelines 10%
• Rate Control 10%
• Rhythm Control 10%
• Short Half-life 10%
• Sulfonyl Group 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 10%
• Amiodarone 20%
• Antiarrhythmic Agent 10%
• Atrial Fibrillation 100%
• Dronedarone 100%
• Heart Failure 30%
• Recurrent Disease 10%
• Sulfonyl 10%